Tudor Investment Corporation »

Bright Minds Biosciences shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $582k 8.3k 70.20

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
Micron Technology Inc - US Equity (MU)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
Tesla Inc - US Equity (TSLA)
Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Advanced Micro Devices Inc - US Equity (AMD)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Bright Minds Biosciences

Jupiter Topco
Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Vestal Point Capital
Braidwell
Driehaus Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Point72 Asset Management
Deerfield Management Company
RA Capital Management
Parkman Healthcare Partners
MPM Oncology Impact Management

View all funds holding Bright Minds Biosciences